Efficacy and Safety of Ayurveda Intervention (AYUSH 64) as add-on therapy for patients with COVID-19 infections – An open labelled, Parallel Group, Randomized controlled clinical trial

bhardwaj P, Godatwar PK, Charan J, Sharma S, Shafi S, Chauhan N, Vyas P, Dutt N, Midha N, Jalandra R, Sharma M, Nag VL, Sharma S, Singh SK, Sharma P, Misra S.

Open source

DOI
10.1101/2021.08.10.21261836
Published
2021-08-17
Container
Not recorded
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 6/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1101/2021.08.10.21261836,
  title = {Efficacy and Safety of Ayurveda Intervention (AYUSH 64) as add-on therapy for patients with COVID-19 infections – An open labelled, Parallel Group, Randomized controlled clinical trial},
  author = {bhardwaj P and  Godatwar PK and  Charan J and  Sharma S and  Shafi S and  Chauhan N and  Vyas P and  Dutt N and  Midha N and  Jalandra R and  Sharma M and  Nag VL and  Sharma S and  Singh SK and  Sharma P and  Misra S.},
  year = {2021},
  doi = {10.1101/2021.08.10.21261836},
  url = {https://doi.org/10.1101/2021.08.10.21261836}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Ayurveda Intervention (AYUSH 64) as add-on therapy for patients with COVID-19 infections – An open labelled, Parallel Group, Randomized controlled clinical trial
AU  - bhardwaj P
AU  -  Godatwar PK
AU  -  Charan J
AU  -  Sharma S
AU  -  Shafi S
AU  -  Chauhan N
AU  -  Vyas P
AU  -  Dutt N
AU  -  Midha N
AU  -  Jalandra R
AU  -  Sharma M
AU  -  Nag VL
AU  -  Sharma S
AU  -  Singh SK
AU  -  Sharma P
AU  -  Misra S.
PY  - 2021
DO  - 10.1101/2021.08.10.21261836
UR  - https://doi.org/10.1101/2021.08.10.21261836
ER  - 

APA

P, B., PK, G., J, C., S, S., S, S., N, C., P, V., N, D., N, M., R, J., M, S., VL, N., S, S., SK, S., P, S., & S., M. (2021). Efficacy and Safety of Ayurveda Intervention (AYUSH 64) as add-on therapy for patients with COVID-19 infections – An open labelled, Parallel Group, Randomized controlled clinical trial. https://doi.org/10.1101/2021.08.10.21261836

Source records